
Alternative investment manager covering private equity, real estate, structured finance and special situations, with a China focus

Gene therapy developer working on heart and central nervous system diseases with a genetic cause

Lexeo Therapeutics is a gene therapy company in New York. It develops treatment candidates for rare inherited conditions and for diseases that affect larger groups of patients. The company grew out of gene therapy research at Weill Cornell Medicine's Department of Genetic Medicine.
Summary written by TrustList from the business's own published information, Oct 2026.
2 images - click to enlarge
Used it? Your experience helps other buyers decide.
Write a reviewNo questions yet. Be the first to ask about Lexeo Therapeutics.
Similar listings buyers compare against this one.

Alternative investment manager covering private equity, real estate, structured finance and special situations, with a China focus

Canadian investor and adviser helping business-to-business enterprise software start-ups grow

Corporate venture arm of an energy company investing in high-growth energy and mobility technology businesses

Member-managed angel and seed capital fund in Indiana and Arkansas investing in early-stage technology businesses

Egyptian startup investor and accelerator running general and fintech tracks for early-stage founders

Venture debt provider financing technology companies from seed stage through to a public listing
Everything here links back to the same verified catalogue. Pick your next stop.